HDR-RALS

高線量率遠隔操作式腔内照射法

WordNet

1. the 8th letter of the Roman alphabet (同)h

PrepTutorEJDIC

1. hydrogenの化学記号
2. 鉛筆の硬度 / 《俗》heroin
3. Regular Army正規軍

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

• 1. HIV抗レトロウイルス療法に関する臨床試験：インテグラーゼ阻害剤 clinical trials of hiv antiretroviral therapy integrase inhibitors
• 2. インテグラーゼ阻害剤の薬理学 pharmacology of integrase inhibitors
• 3. HIV薬剤耐性検査の解釈についての手引 primer on interpretation of hiv drug resistance testing
• 4. 幼児および小児における低カルシウム血症の病因 etiology of hypocalcemia in infants and children
• 5. HIV感染患者における心血管疾患の疫学および危険因子 epidemiology of cardiovascular disease and risk factors in hiv infected patients

English Journal

• Dose error from deviation of dwell time and source position for high dose-rate 192Ir in remote afterloading system.

• Okamoto H1, Aikawa A1, Wakita A1, Yoshio K1, Murakami N1, Nakamura S1, Hamada M1, Abe Y1, Itami J1.
• Journal of radiation research.J Radiat Res.2014 Jul;55(4):780-7. doi: 10.1093/jrr/rru001. Epub 2014 Feb 23.
• The influence of deviations in dwell times and source positions for (192)Ir HDR-RALS was investigated. The potential dose errors for various kinds of brachytherapy procedures were evaluated. The deviations of dwell time ΔT of a (192)Ir HDR source for the various dwell times were measured with a wel
• PMID 24566719

• Phase I trial of concurrent chemoradiation with weekly nedaplatin in patients with squamous cell carcinoma of the uterine cervix.

• Yoshinaga K1, Niikura H, Ogawa Y, Nemoto K, Nagase S, Takano T, Ito K, Yaegashi N.
• Gynecologic oncology.Gynecol Oncol.2007 Jan;104(1):36-40. Epub 2006 Aug 4.
• OBJECTIVE: This phase I clinical trial for cervical carcinoma had three objectives: to evaluate the toxicity of a concurrent chemoradiation regimen featuring weekly nedaplatin; to determine the recommended dose of nedaplatin for a phase II concurrent chemoradiation trial; and to evaluate the formula
• PMID 16889822

• [Measurement of source strength for 192Ir HDR RALS].

• Abe Y.
• Nihon Hōshasen Gijutsu Gakkai zasshi.Nihon Hoshasen Gijutsu Gakkai Zasshi.2006 Dec 20;62(12):1592-7.
• PMID 17233119

Japanese Journal

• 高線量率Ir遠隔治療装置の線源強度測定(<特集>放射線治療論文特集号)

• 阿部 容久
• 日本放射線技術學會雜誌 62(12), 1592-1597, 2006-12-20
• NAID 110006160156

• クロミックフィルムを用いた^<192>Ir-HDR RALS線量分布の検証(放射線治療 小線源・シード, 一般研究発表予稿集, 日本放射線技術学会第33回秋季学術大会)

• 楜澤 淳二,和気 治雄,植草 茂人,仲田 一成,古村 さやか,千吉 良諭,鈴木 理重子,筑間 晃比古
• 日本放射線技術學會雜誌 61(9), 1286, 2005-09-20
• NAID 110004035419

• Results of Radiation Therapy for Uterine Cervical Cancer Using High Dose Rate Remote After Loading System

• , , , , , , , , , ,
• The Tohoku Journal of Experimental Medicine 199(4), 229-238, 2003
• … In Japan, radiotherapy with high dose rate remote after loading system (HDR-RALS) for intracavitary brachytherapy is the standard treatment for more than 30 years. … This report showed the usefulness of HDR-RALS for uterine cervical cancer. … Radiotherapy was performed both external teletherapy and HDR-RALS. …
• NAID 130004459250

---

★リンクテーブル★

リンク元	「高線量率遠隔操作式腔内照射法」
関連記事	「RA」「HD」「H」「RALS」

「高線量率遠隔操作式腔内照射法」

　　[★]

英

high dose rate remotely controlled after loading intracavitary radiotherapy, HDR-RALS

「RA」

　　[★]

• 右房 right atrium
• 関節リウマチ rheumatoid arthritis。慢性関節リウマチ
• レチノイン酸 retinoic acid
• 不応性貧血 refractory anemia

　

「HD」

　　[★]

• ハンチントン病 Huntington's chorea, Huntington's disease Huntington disease
• ホジキン病 Hodgkin disease Hodgkin's disease
• 血液透析 hemodialysis

「H」

　　[★]

• 食道裂孔
• ヒスチジン
• 水素

　 　 　

「RALS」

　　[★] 遠隔操作式後装填法